Literature DB >> 32176569

Multiomics Analysis Coupled with Text Mining Identify Novel Biomarker Candidates for Recurrent Cardiovascular Events.

Constantina Chalikiopoulou1, Barbara Jenko Bizjan2, George Leventopoulos3, Kalliopi Smaili3, Tanja Blagus4, Ariadni Menti3, John Liopetas1, Anne John5, Bassam R Ali5, Vita Dolzan4, George N Hahalis3, George P Patrinos1,5,6, Theodora Katsila1,7.   

Abstract

Recurrent cardiovascular events remain an enigma that accounts for >30% of deaths worldwide. While heredity and human genetics variation play a key role, host-environment interactions offer a sound conceptual framework to dissect the molecular basis of recurrent cardiovascular events from genes and proteins to metabolites, thus accounting for environmental contributions as well. We report here a multiomics systems science approach so as to map interindividual variability in susceptibility to recurrent cardiovascular events. First, we performed data and text mining through a mixed-methods content analysis to select genomic variants, 10 single nucleotide polymorphisms, and microRNAs (miR-10a, miR-21, and miR-20a), minimizing bias in candidate marker selection. Next, we validated our in silico data in a patient cohort suffering from recurrent cardiovascular events (a cross-sectional study design and sampling). Our findings report a key role in low-density lipoprotein clearance for rs11206510 (p < 0.01) and rs515135 (p < 0.05). miR-10a (p < 0.05) was significantly associated with heart failure, while increased expression levels for miR-21 and miR-20a associated with atherosclerosis. In addition, liquid chromatography-mass spectrometry-based (LC-MS-based) proteomics analyses identified that vascular diameter and cholesterol levels are among the key factors to be considered in recurrent cardiovascular events. From a methodology innovation standpoint, this study offers a strategy to enhance the signal-to-noise ratios in mapping novel biomarker candidates wherein each research and conceptual step were interrogated for their validity and in turn, enriched one another, ideally translating information growth to knowledge growth.

Entities:  

Keywords:  biomarkers; cardiovascular events; genomics; genotype and phenotype association; miRNAs; personalized medicine; proteomics

Mesh:

Substances:

Year:  2020        PMID: 32176569     DOI: 10.1089/omi.2019.0216

Source DB:  PubMed          Journal:  OMICS        ISSN: 1536-2310


  3 in total

1.  A novel age-biomarker-clinical history prognostic index for heart failure with reduced left ventricular ejection fraction.

Authors:  Hao Li; Yuan Cui; Jin Tian; Hong Yang; Qing Zhang; Ke Wang; Qinghua Han; Yanbo Zhang
Journal:  Open Med (Wars)       Date:  2020-07-10

2.  An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer's disease.

Authors:  Christopher Clark; Loïc Dayon; Mojgan Masoodi; Gene L Bowman; Julius Popp
Journal:  Alzheimers Res Ther       Date:  2021-04-01       Impact factor: 6.982

Review 3.  Recognized and Potentially New Biomarkers-Their Role in Diagnosis and Prognosis of Cardiovascular Disease.

Authors:  Weronika Bargieł; Katarzyna Cierpiszewska; Klara Maruszczak; Anna Pakuła; Dominika Szwankowska; Aleksandra Wrzesińska; Łukasz Gutowski; Dorota Formanowicz
Journal:  Medicina (Kaunas)       Date:  2021-07-08       Impact factor: 2.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.